HIV-positive cover under the IRDAI 2023 mandate — the gap between the rule and the practice
Bishan Kumar Agarwal
IRDAI mandated that health insurers must consider HIV-positive applicants for cover. The mandate exists. The regulation is real. And yet, when you actually walk into the underwriting room — as we have done with our clients many times — you find a gap between what the rule says and what the practice is. This article is about that gap, and how to navigate it.
Living with HIV and managing it well is not the same as being uninsurable. The two are conflated constantly. Let us separate them.
What the mandate says (without the regulation quote)
Under current IRDAI norms, HIV-positive status cannot be used as a blanket basis for declining a health insurance application. Insurers are required to examine the file on its merits — taking into account the applicant's current health status, ART (antiretroviral therapy) management, viral load, CD4 count, and any co-morbidities.
In plain terms: an insurer who refuses to even look at a file because it says “HIV-positive” is not compliant with how things are supposed to work. That does not always mean they will issue a policy — but it does mean they cannot slam the door shut before examining what is actually in front of them.
What insurers actually do
Compliance is uneven. Some insurers have updated their underwriting guidelines and trained their teams. Others have not. The practical result is that an HIV-positive application submitted to five major insurers on the same day might get five different outcomes — ranging from a policy issued at 50% loading to a flat verbal decline with no written reason.
The insurers who will write HIV-positive files — and there are several — generally require:
- Consistent ART regimen: the same combination therapy for at least 12 months, ideally 24.
- Viral load: undetectable (below 20 copies/mL in most lab standards), or demonstrably declining over 12–18 months.
- CD4 count above 500 cells/mm³, stable over at least 24 months.
- Infectious disease specialist letter confirming stable management and no active opportunistic infections.
Where these markers are present, well-managed HIV is treated as a loading case — not a declination. Loadings of 50–120% are typical, depending on the insurer and the file.
The insurers that will write, and the ones that won't
We will not name individual insurers here — those assessments change with underwriting guidelines, and naming a specific insurer who “declines HIV” today may be inaccurate by the time you read this. What we can tell you from our placed cases: of the major health insurers in India, roughly half will examine and place a well-managed HIV-positive file. The rest routinely decline — sometimes verbally, sometimes without explanation.
The practical implication: do not take a single “no” as the final answer. Work with an advisor who has placed HIV-positive cover before and knows which insurers will genuinely consider the file.
The mandate is real. The friction is real. Both being true is the point.
What changes after you are insured
One important protection that the IRDAI norms establish: once a health policy is issued, the insurer cannot decline renewal on the basis of HIV status alone. Renewal is protected as long as premiums are paid and the terms of the policy are honoured.
This matters because it means the effort of getting issued a policy the first time is not wasted — you are not re-underwritten at every renewal. The loading may stay (it typically does, unless you actively apply for a revised assessment), but the cover continues.
Sub-limits to watch
On some of the lower-tier plans, opportunistic infection cover is capped — either as a sub-limit on the sum assured, or via a long waiting period (often 24 months or more). Before accepting a policy, check specifically what the plan covers for HIV-related complications and at what point. A plan that covers everything except the thing you are most likely to claim on is a poorly structured plan.
Insurance is a contract between you and the insurer. This article is general information only — speak to a licensed advisor about your specific situation before making decisions.
ART non-compliance — declared gaps hurt the application; undeclared gaps hurt the claim
If you have missed ART doses or had treatment gaps, declare them on the form. An undeclared lapse discovered at claim stage is a much worse outcome than a tougher underwriting decision upfront.
Co-morbidities with HIV make the file harder — declare both
Hepatitis B or Hepatitis C co-infection alongside HIV is a more complex underwriting file. Both conditions must be declared. An insurer who declines on HIV alone may decline even more firmly if a co-infection surfaces post-issuance.
Day-1 cover for opportunistic infections — most plans wait 24 months or more
Even where HIV-positive cover is issued, opportunistic infections (OI) typically sit under a specific waiting period clause — often 24 months. Check what the plan covers from day one vs what waits.
If the insurer's first response is ‘we don't write HIV’, try another
A blanket refusal to consider an HIV-positive application is not compliant with current IRDAI norms. That does not mean every insurer is forced to issue a policy — but they are required to examine the file on its merits. Move on to an insurer that will.
39-year-old male, HIV-positive 8 years, well-managed on ART.
39-year-old professional from Delhi. Living with HIV for 8 years. Consistent ART regimen on tenofovir-based combination therapy. Undetectable viral load for the past 3 years. CD4 count 720.
Two insurers declined the application verbally — without issuing a written rejection or examining the file in detail. A third asked for documentation and then went silent.
Compiled a full documentation package: infectious disease specialist letter, 24-month viral load trend (all undetectable), 24-month CD4 trend (stable, consistently above 500), and ART regimen history. Presented to HDFC Ergo with a structured cover letter.
Issued at ₹20L cover with 85% loading. Policy renewed the following year without issue.
We've placed HIV-positive cover 14 times in the last 18 months.
Including cases that two competitors had given up on. If you have been told no, it is worth a second conversation with a team that knows how to present the file.
WhatsApp our team · freeCommon questions.
- Will my employer-provided group cover include me as HIV-positive?
- Most employer group health policies do not individually underwrite employees — everyone is covered under the master policy. HIV status is generally not a basis for excluding an individual from a group plan. However, for any hospitalisation claim related to HIV or its complications, the individual policy will matter much more. Do not rely on group cover as your only layer.
- What if my viral load isn't undetectable yet?
- An undetectable viral load is the strongest signal for underwriters — it shows that ART is working and the disease is well-managed. If your viral load is detectable but trending downward consistently, some insurers will still examine the file. A declining trend over 12–18 months, supported by an ID-specialist letter explaining the trajectory, is more useful than a single number.
- Does the insurer share my HIV status with anyone?
- Insurers are bound by the same data privacy obligations that apply to any sensitive personal health information. They cannot share your HIV status with your employer, family members, or third parties without your consent. The information is used only for the purpose of underwriting and claims processing.
- Can I port out from a corporate group plan that covered me?
- Porting from a group policy to an individual policy is possible under IRDAI portability rules, but the receiving insurer still underwrites the individual application. HIV-positive portability is the same as a fresh application in underwriting terms — your documentation and ART management history will matter. Plan well before your employment ends.
- Are there plans designed specifically for HIV-positive applicants?
- Not a separate ‘HIV plan’ as a standalone product in the Indian market currently. What exists is the mandate that standard health plans must consider HIV-positive applicants on their merits — and several major insurers have updated their underwriting guidelines accordingly. The product you get is a standard health plan; the route to getting it issued is the specialised bit.